980036
Product Name:
Valsartanum, desgewenst in de vorm van een zout of in de vorm van een ester met een hydroxyverbinding met de formule R-OH, waarin R een laagalkyl-, fenyllaagalkyl-, laagalkenyl-, laagal- kynyl-, laagalkoxy-laagalkyl-, laagalkoxy-laagalkenyl- of -----
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
NLO
Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
2011/52
Publication date:
28/12/2011
Description:
Lapse or annulment
2
Bulletin Heading:
MED
Journal edition number:
2011/52
Publication date:
28/12/2011
Description:
Other communications
3
Bulletin Heading:
SPC
Journal edition number:
2011/09
Publication date:
02/03/2011
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
4
Bulletin Heading:
SPC
Journal edition number:
2001/02
Publication date:
01/02/2001
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
5
Bulletin Heading:
SPC
Journal edition number:
1999/02
Publication date:
01/02/1999
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Surrender
Change Kind/ Decision Type:
Total - Renunciation
Deed Number:
016633-A016633-1
Date Registered:
01/12/2011
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Indiening gehele afstand 1 december 2011, ingediend door Nederlandsch Octrooibureau te Den Haag. Op verzoek van de octrooihouder Novartis AG te Bazel, Zwitserland overeenkomstig verordening EEG 1768/92 art. 14 sub b. Zie verder de akte.